ViH Articles

PCN50 A Pilot Assessment to Determine Cost of Apheresis Treatment

Jun 1, 2012, 00:00
PRM2 Network Meta-Analysis of Individual and Aggregate Level Data

Jun 1, 2012, 00:00
PCN54 Evaluating the Inpatient Hospitalization Costs of Treating Prostate Cancer Patients

Jun 1, 2012, 00:00
PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Venezuela

Jun 1, 2012, 00:00
PND28 Mobility, Indirect Costs, and Health-Related Quality of Life in Multiple Sclerosis

Jun 1, 2012, 00:00
PSY47 Pharmacists' Beliefs Regarding Intention to Utilize Prescription Drug Monitoring Program (PDMP) Data

Jun 1, 2012, 00:00
PSY14 Health Care Costs and Opioid Use among Patients With Chronic Low Back Pain Initiating Duloxetine Versus Other Treatments

Jun 1, 2012, 00:00
PCV74 The Relationship Between Hospital Readmission and Post-Discharge Medication Adherence

Jun 1, 2012, 00:00
PDB33 The Associated Costs of Treating Type 2 Diabetes Patients to a Clinically Relevant Composite Endpoint With Liraglutide Versus Exenatide

Jun 1, 2012, 00:00
PMD22 Comparative Cost Between Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression Fractures

Jun 1, 2012, 00:00
PMH21 A Systematic Review of Effect of Antipsychotic Agents on Mortality in Schizophrenia

Jun 1, 2012, 00:00
CE2 Comparative Effectiveness of Monotherapy With Mood Stabilizers Versus Atypical Antipsychotics for the Treatment of Bipolar Disorder in Children and Adolescents- A Retrospective Claims-Data Study

Jun 1, 2012, 00:00
PIN9 A German Hospital Budget Impact Model Comparing Antibiotic Therapies in Complicated Skin and Skin Structure Infections and Bacteremia

Jun 1, 2012, 00:00
PCN15 A Longitudinal Review of Treatment Patterns in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) From Community Practice in the United States

Jun 1, 2012, 00:00
PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients with Hyperphosphatemia

Jun 1, 2012, 00:00
PHP14 Federal Actions Involving Health Care Fraud and Abuse (2006-2010)

Jun 1, 2012, 00:00
PGI30 Hospitalization Burden of Gastro-Intestinal Stromal Tumors

Jun 1, 2012, 00:00
ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

Jun 1, 2012, 00:00
PMS89 Simulation Modeling with System Dynamics (SD) Using Real-World Observational Data to Plan Osteoarthritis Care Delivery in Alberta

Jun 1, 2012, 00:00
PMH64 Anti-Anxiety Medication Utilization among Patients with Anxiety Disorder- Analysis of Medical Expenditure Panel Survey

Jun 1, 2012, 00:00
PRS41 Ethnic Disparities in the Inhaled Corticosteroid Prescription Patterns for Chronic Obstructive Pulmonary Disease

Jun 1, 2012, 00:00
PIN33 Pharmacoeconomic Evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults

Jun 1, 2012, 00:00
PCV30 Analysis of Generic Simvastatin and Atorvastatin Versus Branded Rosuvastatin in Hyperlipidemia Patients- A Budget Impact Model from a Managed Care Organization Perspective in the United States

Jun 1, 2012, 00:00
PDB84 Liberalization of Medical Savings Accounts for Outpatient Treatment and Health Care Utilization Among Type 2 Diabetes Mellitus Patients

Jun 1, 2012, 00:00
PMH40 National Estimates and Potential Predictors of Emergency Department (ED) and Inpatient Care Costs for Events Related to Abuse or Misuse of Opioid Analgesics

Jun 1, 2012, 00:00
PSU37 National Inpatient Burden Associated with Spinal Cord Injuries in the United States

Jun 1, 2012, 00:00
SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons- A Cautionary Tale Concerning Antibiotic Therapy for Infectious Disease

Jun 1, 2012, 00:00
PMS17 Cost Minimization of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

Jun 1, 2012, 00:00
PIN14 Resource Utilization and Costs of Treating Complicated Skin and Skin Structure Infections With Daptomycin or Telavancin

Jun 1, 2012, 00:00
PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings

Jun 1, 2012, 00:00
PCV64 Health Care Resource Utilization and Costs for Acromegaly- A Retrospective Study in a Large Claims Database in the United States

Jun 1, 2012, 00:00
PSS14 Economic Analysis of Etanercept as Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Brazil

Jun 1, 2012, 00:00
PRS22 Cost-Effectiveness of Indacaterol on Patients with Chronic Obstructive Pulmonary Disease (Copd) at the Public Mexican Health Care System

Jun 1, 2012, 00:00
PUK21 Cost-Effectiveness Analysis of Solifenacin Succinate Versus Trospium Chloride in the Treatment of Patients with Overactive Bladder in Germany

Jun 1, 2012, 00:00
PRS23 Economic Analysis of Vorizonazole, Amphotericine B and Caspofungin for Invasive Aspergilosis Patients in Private Hospitals in Dominican Republic

Jun 1, 2012, 00:00
PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

Jun 1, 2012, 00:00
PMH76 Impact of Fda Black Box Warning on the Prescribing of Atypical Antipsychotics in Non-Institutionalized Dementia Patients

Jun 1, 2012, 00:00
PCN23 Incidence of Metastatic Hormone Receptor Positive (HR+) Breast Cancer in the United Kingdom (UK)- Data Needed!

Jun 1, 2012, 00:00
PND35 Fictitious Preferences or Felicitous Recoding? Conjoint Respondents Who Make Sense of Nonsensical Questions

Jun 1, 2012, 00:00
PMH38 Cost-Effectiveness of Asenapine in the Treatment of Schizophrenia in Canada

Jun 1, 2012, 00:00
PSY49 Smoking Cessation Medication Use Among Adult Smokers With Various Body Weight Levels – an NHANES Study

Jun 1, 2012, 00:00
PMH23 Impact of Refill and Save Program on Adherence to Desvenlafaxine and Extended Release Venlafaxine HCl

Jun 1, 2012, 00:00
PCV94 Unpacking the Rapid Grwoth of Pharmaceutical Spending Growth- A Case Analysis of Chinese Hospital

Jun 1, 2012, 00:00
PRS48 The Trends of Child Obesity and the Effect of Child Obesity on Asthma in Young Children

Jun 1, 2012, 00:00
PRS47 Predictors of Willingness to Quit among a Cohort of Adult Smokers in India

Jun 1, 2012, 00:00
PMD45 Variation in Health Related Quality of Life Improvement After Percutaneous Coronary Intervention

Jun 1, 2012, 00:00
PCV18 Evaluation of Response to Loading Doses of Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Jun 1, 2012, 00:00
PIH1 The Clinical Consequences of Exposure to Clinically Important Drug-Drug Interactions

Jun 1, 2012, 00:00
PSY41 Evaluating the Frequency and Sequence of Items Administered Using Promis Computer Adaptive Testing

Jun 1, 2012, 00:00
PCN68 Cost-Effectiveness of HER-2-Positive Metastatic-Breast-Cancer Treatment in Post-Herceptin Progression in Colombia

Jun 1, 2012, 00:00
PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals- An Economic Analysis

Jun 1, 2012, 00:00
PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings

Jun 1, 2012, 00:00
PMD49 Do HTA Requirements and Procurement Incentives in Medical Devices Need Re-Aligning?

Jun 1, 2012, 00:00
Copyright/Subscription

May 1, 2012, 00:00
Agreement between Internet-Based Self- and Proxy-Reported Health Care Resource Utilization and Administrative Health Care Claims

May 1, 2012, 00:00
Decision-Making Criteria among National Policymakers in Five Countries- A Discrete Choice Experiment Eliciting Relative Preferences for Equity and Efficiency

May 1, 2012, 00:00
The EUROHIS-QOL 8-Item Index- Comparative Psychometric Properties to Its Parent WHOQOL-BREF

May 1, 2012, 00:00
QALY Weights for Diabetic Retinopathy—A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO

May 1, 2012, 00:00
Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm

May 1, 2012, 00:00
Do General Practitioners Know Patients' Preferences? An Empirical Study on the Agency Relationship at an Aggregate Level Using a Discrete Choice Experiment

May 1, 2012, 00:00
On Discounting of Health Gains from Human Papillomavirus Vaccination- Effects of Different Approaches

May 1, 2012, 00:00
Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

May 1, 2012, 00:00
Simulated Value-Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with Diabetes

May 1, 2012, 00:00
Australian Managed Entry Scheme- A New Manageable Process for the Reimbursement of New Medicines?

May 1, 2012, 00:00
Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD- A Patient-Level Mixed Treatment Comparison

May 1, 2012, 00:00
Comparison of 7-Day Recall and Daily Diary Reports of COPD Symptoms and Impacts

May 1, 2012, 00:00
Handling Input Correlations in Pharmacoeconomic Models

May 1, 2012, 00:00
A Reply to Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

May 1, 2012, 00:00
Reflections- NICE, Health Economics, and Outcomes Research

May 1, 2012, 00:00
Tails from the Peak District- Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values

May 1, 2012, 00:00
Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and the Friction Cost Approach

May 1, 2012, 00:00
Reasons for Rejection of Patient-Reported Outcome Label Claims- A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010

May 1, 2012, 00:00
Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine

May 1, 2012, 00:00
Condition-Specific Preference-Based Measures- Benefit or Burden?

May 1, 2012, 00:00
A Review of Patient-Reported Outcome Labels in the United States- 2006 to 2010

May 1, 2012, 00:00
Exploring the Relationship between Alzheimer's Disease Severity and Longitudinal Costs

May 1, 2012, 00:00
Guidelines for Health Technologies- Specific Guidance for Oncology Products in Canada

May 1, 2012, 00:00
Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure

May 1, 2012, 00:00
Beyond the FDA PRO Guidan Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels

May 1, 2012, 00:00
Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

May 1, 2012, 00:00
Table of Contents

May 1, 2012, 00:00
Instructions for Authors

May 1, 2012, 00:00
Editorial Board

May 1, 2012, 00:00
Guide for Authors

Mar 1, 2012, 00:00
Informing Shared Decisions about Advance Directives for Patients with Severe Chronic Obstructive Pulmonary Disease- A Modeling Approach

Mar 1, 2012, 00:00
Incorporating Indirect Costs into a Cost-Benefit Analysis of Laparoscopic Adjustable Gastric Banding

Mar 1, 2012, 00:00
Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients

Mar 1, 2012, 00:00
Learning Effects in Time Trade-Off Based Valuation of EQ-5D Health States

Mar 1, 2012, 00:00
Health-Related Quality of Life Measurement in Children and Adolescents in Ibero-American Countries, 2000 to 2010

Mar 1, 2012, 00:00
Patient Access to New Cancer Drugs in the United States and Australia

Mar 1, 2012, 00:00
Innovation and the Burden of Disease- Retrospective Observational Study of New and Emerging Health Technologies Reported by the EuroScan Network from 2000 to 2009

Mar 1, 2012, 00:00
Quality-Adjusted Life Expectancies in Patients with Rheumatoid Arthritis—Comparison of Index Scores from EQ-5D, 15D, and SF-6D

Mar 1, 2012, 00:00
Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function- Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial

Mar 1, 2012, 00:00
Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy

Mar 1, 2012, 00:00
Prospective Observational Studies to Assess Comparative Effectiveness- The ISPOR Good Research Practices Task Force Report

Mar 1, 2012, 00:00
Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia- A Systematic Review

Mar 1, 2012, 00:00
Cost-Effectiveness Analysis of Collaborative Care Management of Major Depression among Low-Income, Predominantly Hispanics with Diabetes

Mar 1, 2012, 00:00
Comparative Effectiveness, Cost, and Utilization of Radical Prostatectomy among Young Men within Managed Care Insurance Plans

Mar 1, 2012, 00:00
Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder

Mar 1, 2012, 00:00
A Review of the Cost of Atrial Fibrillation

Mar 1, 2012, 00:00
Lifetime Cost-Effectiveness of Skin Cancer Prevention through Promotion of Daily Sunscreen Use

Mar 1, 2012, 00:00
Antihypertensive Drugs- A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness

Mar 1, 2012, 00:00
Editorial Board

Mar 1, 2012, 00:00
Pharmaceutical Cost-Containment Policies and Sustainability- Recent Irish Experience

Mar 1, 2012, 00:00
Conducting Comparative Effectiveness Research on Medications- The Views of a Practicing Epidemiologist from the Other Washington

Mar 1, 2012, 00:00
Patient Access to New Cancer Drugs in the United States and Australia—Reply to Letter to the Editor by Dr. Wonder

Mar 1, 2012, 00:00
Can Observational Studies Approximate RCTs?

Mar 1, 2012, 00:00
Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial

Mar 1, 2012, 00:00
Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis

Mar 1, 2012, 00:00
Table of Contents

Mar 1, 2012, 00:00
Comparison of FACT- and EQ-5D–Based Utility Scores in Cancer

Mar 1, 2012, 00:00
Copyright/Subscription

Mar 1, 2012, 00:00
Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases- A Simulation Cohort Study

Jan 1, 2012, 00:00
Eliciting Public Preference for Health-Care Resource Allocation in South Korea

Jan 1, 2012, 00:00
Copyright/Subscription

Jan 1, 2012, 00:00
Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses- Application in Rheumatoid Arthritis

Jan 1, 2012, 00:00
A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan

Jan 1, 2012, 00:00
Erratum

Jan 1, 2012, 00:00
Copyright/Subscription

Jan 1, 2012, 00:00
Extension of Kaplan-Meier Methods in Observational Studies with Time-Varying Treatment

Jan 1, 2012, 00:00
Delisting Policy Reform in South Korea- Failed or Policy Change?

Jan 1, 2012, 00:00
Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea

Jan 1, 2012, 00:00
The Effects of Medication Supply on Hospitalizations and Health-Care Costs in Patients with Chronic Heart Failure

Jan 1, 2012, 00:00
Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea

Jan 1, 2012, 00:00
Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand

Jan 1, 2012, 00:00
Cost-Effectiveness of Nonpharmacologic, Nonsurgical Interventions for Hip and/or Knee Osteoarthritis- Systematic Review

Jan 1, 2012, 00:00
Bridging the Gap in Pharmacoeconomics and Outcomes Research between Researchers, Policymakers, and Practitioners in the Asia-Pacific Region

Jan 1, 2012, 00:00
Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries- Applying a Standardized Costing Methodology

Jan 1, 2012, 00:00
An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore

Jan 1, 2012, 00:00
The Role of the Expected Value of Individualized Care in Cost-Effectiveness Analyses and Decision Making

Jan 1, 2012, 00:00
3rd Special Issue- Pharmacoeconomics Outcomes Research in Asia

Jan 1, 2012, 00:00
Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan

Jan 1, 2012, 00:00
The MacNew Heart Disease Health-Related Quality of Life Questionnaire in Patients with Angina and Patients with Ischemic Heart Failure

Jan 1, 2012, 00:00
Evidence-Based Prediction of Statin Use with Lipid-Panel Data from the National Health and Nutrition Examination Survey

Jan 1, 2012, 00:00
Reviewer Acknowledgement

Jan 1, 2012, 00:00
Further Validation of the Uterine Fibroid Symptom and Quality-of-Life Questionnaire

Jan 1, 2012, 00:00
ISPOR Code of Ethics

Jan 1, 2012, 00:00
The Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Poor Prognosis Advanced Colorectal Cancer (MRC FOCUS)

Jan 1, 2012, 00:00
Health Utility Measured with EQ-5D in Thai Patients Undergoing Peritoneal Dialysis

Jan 1, 2012, 00:00
Clinical and Economic Outcomes Associated with Adjuvant Chemotherapy in Elderly Patients with Early Stage Operable Breast Cancer

Jan 1, 2012, 00:00
Impact of Secondary Cardiovascular Events on Health Status

Jan 1, 2012, 00:00
Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and Malaysia

Jan 1, 2012, 00:00
Stated Preferences of Physicians and Chronic Pain Sufferers in the Use of Classic Strong Opioids

Jan 1, 2012, 00:00
Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model- Comparing Two Antipsychotics in the Treatment of Schizophrenia

Jan 1, 2012, 00:00
Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries

Jan 1, 2012, 00:00
Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting- A Health Economic Model Based on the PREDICTIVE Study

Jan 1, 2012, 00:00
Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan- A Transmission Dynamic Modeling Approach

Jan 1, 2012, 00:00
Editorial Board

Jan 1, 2012, 00:00
Feasibility and Construct Validity of PROMIS and “Legacy” Instruments in an Academic Scleroderma Clinic

Jan 1, 2012, 00:00
Impact of the Introduction of Government Use Licenses on the Drug Expenditure on Seven Medicines in Thailand

Jan 1, 2012, 00:00
Comparing Methods for Identifying Future High-Cost Mental Health Cases in Medicaid

Jan 1, 2012, 00:00
Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand

Jan 1, 2012, 00:00
Table of Contents

Jan 1, 2012, 00:00
Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India

Jan 1, 2012, 00:00
Availability, Health-Care Costs, and Utilization Patterns of Biologics in Taiwan

Jan 1, 2012, 00:00
Economic Implications of the Dynamic Relationship between Antibiotic Use and Hospital-Acquired Infections

Jan 1, 2012, 00:00
Evidence to Inform Decision Makers in Thailand- A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis

Jan 1, 2012, 00:00
Table of Contents

Jan 1, 2012, 00:00
Cost-Effectiveness of Maintenance Pemetrexed in Patients with Advanced Nonsquamous-Cell Lung Cancer from the Perspective of the Swiss Health Care System

Jan 1, 2012, 00:00
The Burden of Illness for Patients with Viral Hepatitis C- Evidence from a National Survey in Japan

Jan 1, 2012, 00:00
Priority Symptoms in Advanced Breast Cancer- Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

Jan 1, 2012, 00:00
Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea

Jan 1, 2012, 00:00
Guide for Authors

Jan 1, 2012, 00:00
Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods

Jan 1, 2012, 00:00
Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary

Jan 1, 2012, 00:00
Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies- Influence of Differences in Modeling Methods on Outcomes

Jan 1, 2012, 00:00
The Performance of a Value Set for the EQ-5D Based on Experienced Health States in Patients with Inflammatory Bowel Disease

Jan 1, 2012, 00:00
A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders

Jan 1, 2012, 00:00
Modeling the Effects of H1N1 Influenza Vaccine Distribution in the United States

Jan 1, 2012, 00:00
Drug Reimbursement Decision-Making in Thailand, China, and South Korea

Jan 1, 2012, 00:00
Instructions for Authors

Jan 1, 2012, 00:00
National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia- Drug Listing Changes and Opportunities

Jan 1, 2012, 00:00
Editorial Board

Jan 1, 2012, 00:00
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil

Dec 1, 2011, 00:00
Prioritizing Pharmacogenetic Research- A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment

Dec 1, 2011, 00:00
Assuring the Patient Centeredness of Patient-Reported Outcomes- Content Validity in Medical Product Development and Comparative Effectiveness Research

Dec 1, 2011, 00:00
Social Valuation of EQ-5D Health States- The Chilean Case

Dec 1, 2011, 00:00
Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease

Dec 1, 2011, 00:00
Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C

Dec 1, 2011, 00:00
Elicitation of Informed General Population Health State Utility Values- A Review of the Literature

Dec 1, 2011, 00:00
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 2—Assessing Respondent Underst ...

Dec 1, 2011, 00:00
Guide for Authors

Dec 1, 2011, 00:00
The National Institute for Health and Clinical Excellence Single Technology Appraisal Process- Lessons from the First 4 Years

Dec 1, 2011, 00:00
DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries

Dec 1, 2011, 00:00
Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research- How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size

Dec 1, 2011, 00:00
Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens- Combined Results of Two German Self-Report Surveys

Dec 1, 2011, 00:00
Effect of Health-Related Quality-Of-Life Instrument and Quality-Adjusted Life Year Calculation Method on the Number of Life Years Gained in the Critical Care Setting

Dec 1, 2011, 00:00
Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis

Dec 1, 2011, 00:00
Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa- Estimates Based on DART Trial Results and Costs for Uganda and Kenya

Dec 1, 2011, 00:00
EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children- A Systematic Methodological Review

Dec 1, 2011, 00:00
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 1—Eliciting Concepts for a New ...

Dec 1, 2011, 00:00
Methods for Using Data Abstracted from Medical Charts to Impute Longitudinal Missing Data in a Clinical Trial

Dec 1, 2011, 00:00
Cost-Utility Analyses of Diagnostic Laboratory Tests- A Systematic Review

Dec 1, 2011, 00:00
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

Dec 1, 2011, 00:00
Editorial Board

Dec 1, 2011, 00:00
Response Burden and Questionnaire Length- Is Shorter Better? A Review and Meta-analysis

Dec 1, 2011, 00:00
Reviewer Acknowledgment

Dec 1, 2011, 00:00
Copyright/Subscription

Dec 1, 2011, 00:00
Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa- Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falci ...

Dec 1, 2011, 00:00
Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease- A US Payer Perspective

Dec 1, 2011, 00:00
When Evaluating Parameter Uncertainty Is Not Enough- The Case of Dasatinib and Nilotinib for Imatinib-Resistant Chronic Myeloid Leukemia

Dec 1, 2011, 00:00
Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer- A Discrete Choice Experiment

Dec 1, 2011, 00:00
Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire

Dec 1, 2011, 00:00
Estimating Population-Based Values for EQ-5D Health States in Thailand

Dec 1, 2011, 00:00
Table of Contents

Dec 1, 2011, 00:00
PSS3 Un Estudio De Costo-Efectividad Para Evaluar El Tratamiento Con N-Acetil Cisteína En Pacientes Con Esclerosis Sistémica

Nov 1, 2011, 00:00
PIN35 Costs of Managing Genital Warts in the UK

Nov 1, 2011, 00:00
PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland

Nov 1, 2011, 00:00
PCV1 Explorative Analysis about the Appropriateness of a GPS Longitudinal Database on Evaluating Atypical Antipsychotics in Terms of Drugs Adverse Events

Nov 1, 2011, 00:00
PCV119 Relationship Between Quality of Life and Level of Cardiovascular Risk and Comorbidities in Spanish Hipertensive Patients-Alhambra Study

Nov 1, 2011, 00:00
PND57 Effect of Treatment Timing on Risk of Institutionalization Among Patients with Alzheimer'S Disease

Nov 1, 2011, 00:00
PDB62 The Impact of Clinical Inertia in the Treatment of Type 2 Diabetes

Nov 1, 2011, 00:00
PRS19 Quality of Life and Economics of Asthma Control in France and Spain- Final Results of the EU-Coast Study

Nov 1, 2011, 00:00
PMS39 Economic Evaluation of Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis in Mexico

Nov 1, 2011, 00:00
PMS9 What is the Value of the New Kid on the Block?- tocilizumab versus Abatacept for Rheumatoid Arthritis in Colombia

Nov 1, 2011, 00:00
PHP102 Biosimilars- Pricing Reimbursement in Germany- Key Insights From Sickness Funds

Nov 1, 2011, 00:00
PHP22 Use of Decision Modeling to Estimate the Negative Impact of Tobacco Use on Health Care Costs and Health Disparities in People Living with HIV

Nov 1, 2011, 00:00
PRS73 Systematic Review of the Guidelines on the Prevention of Allergic Manifestations in Children

Nov 1, 2011, 00:00
PHP27 The Economic Benefits of Implementing A Unit Dose Drug Dispensing System at the Hospital Level in the Mexican Institute of Social Security (IMSS)

Nov 1, 2011, 00:00
PIH20 the Burden of Endometriosis- Costs and Quality of Life of Women with Endometriosis Treated in Referral Centres

Nov 1, 2011, 00:00
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma

Nov 1, 2011, 00:00
PSS44 Using Structural Equation Modeling to Investigate the Association of Treatment Satisfaction With Disease Severity and Health Related Quality of Life

Nov 1, 2011, 00:00
PIN103 A Comparison of Investments for Different Prevention Programs- Respiratory Syncytial Virus Prophylaxis Versus Human Papilloma Vaccine

Nov 1, 2011, 00:00
PCV104 Persistence in Hypertension Treatment with Olmesartan Medoxomil Versus Valsartan - Analysis of Real-Life Prescription Data in Germany

Nov 1, 2011, 00:00
TP2 Patrones De Tratamiento De La Leucemia Mieloide Crónica (Lmc) En Pacientes Resistentes O Intolerantes A Imatinib En Instituciones De Salud Pública En México

Nov 1, 2011, 00:00
IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3- COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian Protocol

Nov 1, 2011, 00:00
PMS12 A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy

Nov 1, 2011, 00:00
PRM56 Differential Discounting- Questioning the Assumption of Healthcare Resource Fungibility Over Time

Nov 1, 2011, 00:00
PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer- Comparing the Three Schemes Standards- FOLFOX-4, FLOX and XELOX

Nov 1, 2011, 00:00
PMD41 Drug Eluting Stent (DES) versus Bare Metal Stent (BMS) on Clinical, Humanistic and Economic outcomes- A 12-Month Prospective Observational Study

Nov 1, 2011, 00:00
PIN22 Comparison of Two Dynamic Models Predicting Future Burden of Illness of Hepatitis C (HCV) in the EU-5 (France, Germany, Italy, Spain, UK)

Nov 1, 2011, 00:00
PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France

Nov 1, 2011, 00:00
PGI15 The Cost and Quality of Life of Hepatitis C in the Netherlands

Nov 1, 2011, 00:00
PMS62 Improved Fatigue and Physical Function are Correlated with Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated with Apremilast- Results from a Phase 2, Randomized, Controlled Study

Nov 1, 2011, 00:00
PMD17 Noble Metal Alloy-Coated Urethral Catheter- A Budget Impact analysis in the Veneto Region of Italy

Nov 1, 2011, 00:00
PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study- Excess Burden Due to Relapses

Nov 1, 2011, 00:00
PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American Countries

Nov 1, 2011, 00:00
PSY11 Evaluacion Economica Del Uso Profilactico De Pegfilgastrim En Pacientes Con Quimioterapia Miloablativa Para Evitar La Neutropenia Febril

Nov 1, 2011, 00:00
PSS2 Encouraging The Efficiency Of The National Transplant PROGRAM- Estimating The Cost Of Corneal Transplant To Be Financed By Public Institutions In The Health Sector In MEXICO

Nov 1, 2011, 00:00
PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?

Nov 1, 2011, 00:00
PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis- Comparative Results From 5 European Countries

Nov 1, 2011, 00:00
PHP116 Clincal and Economic Evidence Bases for Health Technology Assessment- A Comparison of Three Jurisdictions

Nov 1, 2011, 00:00
PGI29 Quality of Life in Chronic Liver Disease

Nov 1, 2011, 00:00
PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals

Nov 1, 2011, 00:00
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World Data

Nov 1, 2011, 00:00
CV3 Análisis De Costo Efectividad En El Cierre De La Comunicación Interatrial Ostium Secundum- Técnica Percutánea Versus Quirúrgica

Nov 1, 2011, 00:00
PUK4 COSTO-Efectividad De Intervenciones Para Insuficiencia Renal CRÓnica Terminal En MÉXICO

Nov 1, 2011, 00:00
PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular Outcomes

Nov 1, 2011, 00:00
PIH38 Self Reported Health Status and Quality of Life Among Coastal Rural Population in South India

Nov 1, 2011, 00:00
PRM64 The Role of the Instrument Developer in the Translation of Patient Reported Outcome Measures

Nov 1, 2011, 00:00
PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

Nov 1, 2011, 00:00
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

Nov 1, 2011, 00:00
PMH49 Development and Content Validity of a Patient Reported Outcomes Measure to Assess Symptoms of Major Depressive Disorder (MDD)

Nov 1, 2011, 00:00
PCV88 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndromes from a Brazilian Public Healthcare perspective Based on Data from the Plato Trial

Nov 1, 2011, 00:00
CV4 Cost-Effectiveness of Implantable Cardioverter-Defibrillator in Patients With Risk Factors for Sudden Death in Argentina

Nov 1, 2011, 00:00
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in Germany

Nov 1, 2011, 00:00
PMD33 Economic Evaluation of Two Wound Dressings for Children with Partial-Thickness Scalds from the Public Payer Perspective

Nov 1, 2011, 00:00
PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in Brazil

Nov 1, 2011, 00:00
PIN87 Hepatitis C Treatment Continuation Rates in Treatment-Naïve Genotype 1 Patients in the Brazilian Public Health Care System

Nov 1, 2011, 00:00
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in Italy

Nov 1, 2011, 00:00
PCV71 Sponsorship and Pharmacoeconomic Conclusions of Studies on Statin Use for Cardiovascular Prevention- A Systematic Analysis

Nov 1, 2011, 00:00
PHP63 Savings on Pharmaceutical Expenditure in Greek NHS Hospitals Under the Shadow of the International Monetary Fund (IMF)

Nov 1, 2011, 00:00
PCN179 Clinical Trials in Oncology in Greece

Nov 1, 2011, 00:00
HT3 Understanding the Complexity of HTA Networks

Nov 1, 2011, 00:00
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)

Nov 1, 2011, 00:00
PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak Republic

Nov 1, 2011, 00:00
PIH10 Examination of Female Balance Maintenance Ability in Major Life Stages

Nov 1, 2011, 00:00
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary Disease

Nov 1, 2011, 00:00
PDB52 Adherence with Oral Medications for Diabetes Among Brazilian Patients- A Systematic Review of National Literature

Nov 1, 2011, 00:00
PSY28 Cost-Effectiveness Analysis Comparing Epidural, Patient-Controlled Iv Morphine, and Continuous Wound Infiltration for Postoperative Pain Management After Abdominal Surgery

Nov 1, 2011, 00:00
PCV147 Framingham Risk Score in Health Economic Modelling- A European Perspective

Nov 1, 2011, 00:00
PCV77 Economic Evaluation of Dabigatran Etexilate 150dib for the Stroke Prevention in Atrial Fibrillation in Gree A Cost –Effectiveness Analysis under the Greek NHS Setting

Nov 1, 2011, 00:00
PMH64 Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia- A Three-Year Follow-up of Hypoglycemic Therapy

Nov 1, 2011, 00:00
PRS35 Economic Evaluation of Indacaterol Versus Tiotropium or Formoterol for Patients with Moderate to Severe Copd in Greece

Nov 1, 2011, 00:00
PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting

Nov 1, 2011, 00:00
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)

Nov 1, 2011, 00:00
PHP35 Perceptions, Knowledge and Gaps about HTA and Health Economics by the Braziian Market Stakeholders- Ispor Brazil Qualitative Research

Nov 1, 2011, 00:00
PCN125 Elicitation of Health State Utilities in Neuroendocrine Tumours

Nov 1, 2011, 00:00
PMS63 New Developments in the Ankylosing Spondylitis Quality of Life (ASQOL) Scale

Nov 1, 2011, 00:00
PMS3 Differentiation of Osteoporosis Treatments Action on Bone Remodeling- Principal Components Analysis of Bone Histomorphometry Parameters

Nov 1, 2011, 00:00
PMS17 The Effect of Biological Treatment on Work Productivity and Productivity Costs of Rheumatoid Arthritis Patients

Nov 1, 2011, 00:00
PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies

Nov 1, 2011, 00:00
PCV97 Cost-Effectiveness Analysis of Public Health Interventions to Prevent Obesity in New Zealand

Nov 1, 2011, 00:00
PRM45 Importance of Collaboration with Developers in the Clarification of Concepts- A Case Study with the University of California, San Diego (UCSD) Shortness of Breath Questionnaire (SOBQ)

Nov 1, 2011, 00:00
PRM38 Estimating SF-6D Health State Utility Values for Comorid Health Conditions

Nov 1, 2011, 00:00
PUK2 Cost Per Successful Response Of Standard Treatment Plus Cinacalcet Versus Standard Treatment Alone In Patients With Secondary Hyperparathyroidism In MEXICO

Nov 1, 2011, 00:00
HG1 Applying Frailty Model in Longitudinal Survivals of Chronic Diseases

Nov 1, 2011, 00:00
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary Disease

Nov 1, 2011, 00:00
PSS45 Treatment Patterns, Treatment Satisfaction, Disease Severity and Quality of Life in Patients with Psoriasis in Denmark, Finland, and Sweden

Nov 1, 2011, 00:00
CN4 Heterogeneity In Predicting The Future Impact Of Technologies To Control Hepatocellular Carcinoma (HCC)- A Comparison Of Stakeholder Views From Europe And Asia

Nov 1, 2011, 00:00
PIN1 Pharmacist Participation in Antiretroviral Drug Monitoring for the Prevention of Mother-to-Child Transmission of HIV at Warinchumrab Hospital, Ubonratchathani, Thailand

Nov 1, 2011, 00:00
PND65 Describing and Comparing Utility from EQ-5D and SF-6D in A Huntington'S Disease Population

Nov 1, 2011, 00:00
PCN84 Population Vaccination Program for Human Papillomavirus in Spanish Girls- An Efficiency Study

Nov 1, 2011, 00:00
PHP21 Adoption of New Medicines in the OECD- Regulation, Innovation and Scale

Nov 1, 2011, 00:00
PSU20 Estimating Preferences for Economic Evaluation in Patients with Localized Prostate Cancer

Nov 1, 2011, 00:00
PMH67 Drug Utilisation Adaptations in Sweden After the Effexor Patent Expiry

Nov 1, 2011, 00:00
PCV108 Deriving Utility Values from the General Population for Dronedarone in the Treatment of Atrial Fibrillation

Nov 1, 2011, 00:00
PCV135 Low Lipoprotein Cholesterol Goal Attainment in Dyslipidemic Patients with Existing Statin therapy- A Chart Extraction-Based Approach

Nov 1, 2011, 00:00
PMH58 Donepezil Oral Disintegrating Versus Donepezil Standard Tablets on Objective Burden of Caregivers of NaÏve Patients with Alzheimer'S Disease

Nov 1, 2011, 00:00
PRS22 Estimation of Direct and Inderct Costs of COPD in Ukraine- The Pilot Study Results

Nov 1, 2011, 00:00
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B Patients

Nov 1, 2011, 00:00
PMS45 Cost-Utility and Budget Impact Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-to-Severe Active Rheumatoid Arthritis in Greece

Nov 1, 2011, 00:00
PSU18 Cost-Utility Analysis of Laparoscopic Versus Open Surgery for Colorectal Cancer

Nov 1, 2011, 00:00
PCN136 Cancer Patients' Perceptions Towards the Integration of Traditional CM) into the Conventional Cancer Treatment- A Qualitative Insight

Nov 1, 2011, 00:00
PIN28 Consumption Pattern and the Cost Analysis of Parenteral Antibiotics in A

Nov 1, 2011, 00:00
PCN99 Cost-Effectiveness of Dasatinib versus High-Dose Imatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia Resistant to Standard-Dose Imatinib in Portugal

Nov 1, 2011, 00:00
PHP85 A Systematic Review of Automated Dose Dispensing in Primary Health Care

Nov 1, 2011, 00:00
PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

Nov 1, 2011, 00:00
PCV22 Geographic Variation Trends in Critical Limb Ischemia Prevalence in the United States

Nov 1, 2011, 00:00
PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive Patients

Nov 1, 2011, 00:00
PIN70 Modelling the Epidemiological Impact of Rotavirus Vaccination to Assess its Cost-Effectiveness in England and Wales

Nov 1, 2011, 00:00
PIH37 The Royal Road or the Middle Way? Public and Patient Preferences for Health Outcomes

Nov 1, 2011, 00:00
PCN186 An Epidemiological Evaluation of Chemotherapy Used in the Treatment of Metastatic Prostate Cancer

Nov 1, 2011, 00:00
PCN18 Intermittent Versus Continuous Chemotherapy for First-Line Treatment of Unresectable Metastatic Colorectal Cancer (CCRm)- Systematic Review and Meta-Analysis

Nov 1, 2011, 00:00
PCV40 Budget Impact Model After the Introduction of Vernakalant in Spain

Nov 1, 2011, 00:00
PCN170 Direct Costs of Head and Neck Cancer in the US- An Analysis Using 2008 Medical Expenditure Panel Survey (MEPS) Data

Nov 1, 2011, 00:00
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal Origin

Nov 1, 2011, 00:00
PIN27 Cost analysis of the Consumed Oral Antibiotics in a Tertiary Care

Nov 1, 2011, 00:00
NI2 The Impact of Nice Guidance on the Diffusion of Medical Devices

Nov 1, 2011, 00:00
PND60 An Examination of Medication Treatment Patterns Among Patients with Parksinson'S Disease Who Utilize Rasagiline or Selegiline

Nov 1, 2011, 00:00
PCN78 Review of the Recent Pharmaceutical Additions to the Treatment of Colorectal Cancer

Nov 1, 2011, 00:00
PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia

Nov 1, 2011, 00:00
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic Rhinoconjunctivitis

Nov 1, 2011, 00:00
PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast Cancer

Nov 1, 2011, 00:00
PCV122 How Patients with Chronic Stable Angina Perceive and Live with their Disease on an Everyday Basis?

Nov 1, 2011, 00:00
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus

Nov 1, 2011, 00:00
PCV31 Cerebral Hemorrhage and Transient Ischemic Attack Affected by Meteorological Factors

Nov 1, 2011, 00:00
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in Mexico

Nov 1, 2011, 00:00
PHP118 Analysis of Pricing Reimbursement Approval Process for New Drugs in Korea Under Newly-Introduced HTA Environment (2007-2010)

Nov 1, 2011, 00:00
PHP111 ISPOR- Awareness, Drivers and Barriers to Involvement of UK Cancer Network Stakeholders

Nov 1, 2011, 00:00
PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer Patients

Nov 1, 2011, 00:00
PHP100 Did Iqwig‘S Drug Appraisals in Connection with G-BA‘S Directives Change Prescribing Behavior of German Physicians?

Nov 1, 2011, 00:00
PHP106 when is Lower Level Evidence of Effectiveness Acceptable in Reimbursement Decisions?- A Decision Algorithm to Guide Policy Makers

Nov 1, 2011, 00:00
PHP105 Cost-Effectiveness in Drug Reimbursement Decision Making- A Toothless Tiger?

Nov 1, 2011, 00:00
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on ...

Nov 1, 2011, 00:00
PCV144 Stroke Prevention in Patients with Atrial Fibrillation- Inappropriate Anticoagulation and Poor INR Control

Nov 1, 2011, 00:00
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association- How Much Does Cost-Effective Treatment Cost?

Nov 1, 2011, 00:00
PIN62 A Multidisciplinary Support program in Hepatitis C Treatment- An Economic Evaluation

Nov 1, 2011, 00:00
PHP28 Drugs for Rare Diseases- Influence of Oprhan Designation Status on Price

Nov 1, 2011, 00:00
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver Toxicity

Nov 1, 2011, 00:00
VI2 A Novel Approach to analysing Value Driver Importance Across Multiple Target Product Profiles

Nov 1, 2011, 00:00
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden- The Example of Myocardial Infarction

Nov 1, 2011, 00:00
PDB41 The Cost-Effectiveness of Getting to Glucose, Blood Pressure, and Lipid Goals in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

Nov 1, 2011, 00:00
PIH22 Cost Effectiveness of an infant Pneumococcal Conjugate Vaccine program in China

Nov 1, 2011, 00:00
PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries- Results from the Lupus European Online (Leo) Survey

Nov 1, 2011, 00:00
PHP120 The Past As Prologue- Use of Comparative Effectiveness Reviews (CER) in National Coverage Decision Making by Medicare in the United States and Predictions on Future Use of CER

Nov 1, 2011, 00:00
PSY56 Effect of Worksite Weight Management Program on Workers Productivity

Nov 1, 2011, 00:00
PCV39 Heparin-Induced Thrombocytopenia Type II in Times of Demographic Changes – Epidemiological and Economic Aspects in Germany

Nov 1, 2011, 00:00
PRM10 to Get the Right Price – A Decision Support Method to Optimize Managerial Decisions on Public Funding Price to Apply for

Nov 1, 2011, 00:00
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in Poland

Nov 1, 2011, 00:00
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the Elderly

Nov 1, 2011, 00:00
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic Review

Nov 1, 2011, 00:00
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in Colombia

Nov 1, 2011, 00:00
PHP42 Calidad De Vida Relacionada Con La Salud Y Apoyo Social En Estudiantes De Farmacia En Venezuela

Nov 1, 2011, 00:00
PHP55 A Review of the Nice Appeals Process

Nov 1, 2011, 00:00
PMD65 Systematic Review of Studies of the Efficiency of Negative Pressure therapy for Complex Foot Wounds in Diabetic Patients

Nov 1, 2011, 00:00
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population

Nov 1, 2011, 00:00
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and Belgium

Nov 1, 2011, 00:00
PCN164 Does Different Availability of Oncology Care is Responsible for Differences in Cancer-related Mortality Rates Among the Provinces of Poland?

Nov 1, 2011, 00:00
PCN175 Reimbursement of Anticancer Drugs in Canada- What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?

Nov 1, 2011, 00:00
PND4 El Impacto Economico Del Tabaquismo En El Desarrollo De La Enfermedad Vascular Cerebral En Un Centro Neurologico De Tercer Nivel

Nov 1, 2011, 00:00
PIN33 Economic Impact of the Antiretroviral Pharmacotherapy on Cost and HIV/AIDS Control in Bulgaria

Nov 1, 2011, 00:00
HS1 Interchangeability Between Pneumococcal Conjugate Vaccines and Schemes

Nov 1, 2011, 00:00
PHP37 Cross-Continental Comparison of HTA Evolution in Emerging Markets- Brazil, India and Poland

Nov 1, 2011, 00:00
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Panama

Nov 1, 2011, 00:00
PDB80 Validation of the Updated Charlson Comorbidity Index (CCI) for Use in Patients with Diabetes or Asthma- A Comparison Study

Nov 1, 2011, 00:00
PCN54 Hospital Costs Related to Hepatitis C Virus Infection- First Analysis of the French Hospital National Data Base

Nov 1, 2011, 00:00
PND30 Cost-Effectiveness of Early vs. Non-Early Intervention in Acute Migraine with Almotriptan in Spain

Nov 1, 2011, 00:00
PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In Argentina

Nov 1, 2011, 00:00
PMD44 Economic Evaluation of the UGT1A1 Pharmacogenetic Test to inform Dose Selection of Irinotecan-Based Chemotherapy

Nov 1, 2011, 00:00
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study)- French Results

Nov 1, 2011, 00:00
PCV99 Utilisation of Renin –Angiotensin System Agents Involved in Treatment of Cardiovascular Diseases in Slovak Republic

Nov 1, 2011, 00:00
PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS)- A Dutch Analysis Based on the Plato Trial

Nov 1, 2011, 00:00
PRM9 What Guidance is Available for Budget Impact Analysis?

Nov 1, 2011, 00:00
PIH25 Cost-Effectiveness of Interventions Against Childhood Obesity

Nov 1, 2011, 00:00
PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort

Nov 1, 2011, 00:00
PUK5 ANÁlisis Comparativo De Costos Del Tratamiento Para La Anemia Renal Con Metoxi POLIETILENGLICOL-Eritropoyetina Beta (MIRCERA®) VS. Eritropoyetina ALFA

Nov 1, 2011, 00:00
PHP47 Evaluation of General Public'S Expenditure on Health Products

Nov 1, 2011, 00:00
PIN15 Trends in Varicella-Zoster Incidence in the Netherlands Boosting Effect Within Households

Nov 1, 2011, 00:00
PHP50 Irrational Use of Injectable Form of Dexamethasone- A Warning for Health System in Iran

Nov 1, 2011, 00:00
PIN60 Cost-Effectiveness of Telbivudine in First Line Treatment of Hbeag-Positive Patients with Chronic Hepatitis B (CHB) in the Turkish Health Care Setting

Nov 1, 2011, 00:00
PHP127 Impact of Patient Access Schemes on NICE and SMC Guidance

Nov 1, 2011, 00:00
PCV129 Discrepancies Between Defined Daily Doses and Actual Prescription Patterns in the Polish Setting- the ACE Inhibitors Example

Nov 1, 2011, 00:00
PSS25 the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Observation for the Treatment of Macular Oedema Following Central and Branch Retinal Vein Occlusion

Nov 1, 2011, 00:00
PSS7 Prevalence Assessment of Diabetic Macular Edema With Visual Impairment in Spain- A Prevail Study

Nov 1, 2011, 00:00
PMS33 Economic Evaluation of intravenously Ibandronate for the Treatment of Postmenopausal Osteoporosis in Mexico

Nov 1, 2011, 00:00
PGI9 Impact of Dysphagia on U.S. Hospital Charges in Patients with Comorbid Conditions

Nov 1, 2011, 00:00
PMH25 Cost of Delivering Psychiatric Inpatient Care to Mental Health Patients with Psychosis and Co-Occuring Substance Use- A UK-Based Study

Nov 1, 2011, 00:00
PMD66 Demand for Routine in office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

Nov 1, 2011, 00:00
PDB12 Glargine Utilisation in Russia- A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPH

Nov 1, 2011, 00:00
PCN197 Health Related Quality of Life in Long Term Survivors of Lymphoma- A Population Based Study

Nov 1, 2011, 00:00
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection ...

Nov 1, 2011, 00:00
PDB43 The Economic Impact of Weight Loss in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

Nov 1, 2011, 00:00
PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, Ghana

Nov 1, 2011, 00:00
PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?

Nov 1, 2011, 00:00
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological Therapy

Nov 1, 2011, 00:00
PCN196 Review of Cost Effectiveness of Trastuzumab in Early Breast Cancer

Nov 1, 2011, 00:00
PRM63 Multiple Choices - How to Make Rational Decisions Across Several Interventions When Faced with Different Outcomes and Perspectives?

Nov 1, 2011, 00:00
PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia- Evidence from the Catie Study

Nov 1, 2011, 00:00
PDB65 Unmet Need and Drug Management Challeneges in Elderly Type 2 Diabetes Medicare Part D Population

Nov 1, 2011, 00:00